Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14004614 | 1.00 | MAPT (0.33) | MAPTGAATP53SMN1; SMN2KDM4E | |
| SCHEMBL14004595 | 0.95 | TP53 (0.32) | MAPTGAATP53SMN1; SMN2KDM4E | |
| SCHEMBL14004604 | 0.95 | TP53 (0.32) | MAPTGAATP53SMN1; SMN2KDM4E | |
| SCHEMBL14004630 | 0.90 | KMT2A (0.32) | GAASMN1; SMN2KMT2A | |
| SCHEMBL14004608 | 0.88 | PRMT1 (0.40) | MAPTGAATP53SMN1; SMN2KDM4E | |
| SCHEMBL14004599 | 0.88 | PRMT1 (0.40) | MAPTGAATP53SMN1; SMN2KDM4E | |
| SCHEMBL14004584 | 0.84 | KDM4E (0.34) | MAPTSMN1; SMN2KDM4EALDH1A1RXFP1 | |
| SCHEMBL14004589 | 0.84 | KDM4E (0.34) | MAPTSMN1; SMN2KDM4EALDH1A1RXFP1 | |
| SCHEMBL14004613 | 0.83 | PRMT1 (0.36) | MAPTKDM4EALDH1A1RXFP1KMT2A | |
| SCHEMBL14004615 | 0.83 | PRMT1 (0.36) | MAPTKDM4EALDH1A1RXFP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-11-27 | — | — | US | disclosed |
| WO-2007006594-A2 | REACTIVE AZO DYES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | IK, CYP1A1, ALKBH1 | MAPT 3286/4885GAA 3543/4885TP53 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.